Ruby Bio
United States · $8.2M raised
- Business Model
- B2B
- Website
- rubybio.com
- Total Funding
- $8.2M
- Last Round
- $158K GrantAug 2025
- Rounds
- 2
About
Biotech company transforming low-cost sugar into high-value biodegradable non-toxic products via yeast-based biosynthesis.
Summary
Ruby Bio is a Biotech company based in United States. It has raised $8.2M in total across 2 rounds, most recently a $158K Grant round in Aug 2025. Investors include Alumni Ventures, Fusion Fund and gener8tor.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Apeel Sciences develops plant-based edible coatings that extend the shelf life of fresh produce, ...
Decarbonizing the chemicals industry.
A pioneer in the cell-based meat industry.
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...